Hmm

http://www.nytimes.com/2006/01/16
/science/16gene.html?incamp=article_popular

So the diabetes world just got a little more interesting. Another gene associated with a predisposition to DM 2 has been identified. I can see the pharmaceutical giants licking their fingers at the possibility of a new target for therapy. The world of diabetes therapy already has such a bewildering range of drugs many of them entire new groups that came out in the last decade. If a disease has many possible treatments it usually means that none of them present a clear advantage and less is known about the disease itself. So basically in medicine choice is bad. And so it is with Diabetes.